Trademark: HAEMATOKINE 2185608
Word
HAEMATOKINE
ID
2185608
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
05 February 2021
Registration Date
05 February 2021
Renewal Date
05 February 2031

Service

Goods and Services:
Class 5:
Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; stem cells; stem cells for medical purposes; tumor suppressing agents; antineoplastics; anti-neoplastic preparations of chemical origin; anti-neoplastic preparations of microbial origin; anti-cancer preparations; compounds for treating cancer; antibodies; antibodies for medical use to treat inflammation and cancer growth and spread; adjuvants for medical purposes; vaccine adjuvants; biological adjuvants for medical purposes; anti-inflammatories; antigens; antitumor drugs; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical use; culture media for medical use; media for bacteriological cultures; cell growth media for growing cells for medical use; biological preparations for medical purposes; mixed biological preparations for medical purposes; biological preparations for veterinary purposes; immunomodulators; immunostimulants; injectable pharmaceuticals; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of tumours; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances with anti-inflammatory properties; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for the prevention of disorders of the immune system; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of disorders caused by bacteria; pharmaceutical preparations for the treatment of diseases caused by bacteria; pharmaceutical preparations for the prevention of disorders of the respiratory system; pharmaceutical preparations for the prevention of inflammatory disorders; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for the prevention of inflammatory diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in tissue transplantation; pharmaceutical products for the treatment of bone diseases; regulatory proteins for medical use; serotherapeutic medicines; synthetic peptides for pharmaceutical purposes; pharmaceutical products for treating respiratory diseases; compounds for treating respiratory diseases; pharmaceutical preparations for treating respiratory diseases; compounds for treating correlated pulmonary syndromes; pharmaceutical preparations for treatment and prevention of ischemic conditions, inflammation and organ damages resulting from tissue traumas, reperfusion injuries, cancer, cancer metastasis, inflammatory conditions and allergic conditions; pharmaceutical preparations for treatment and prevention of multi-organ failure, acute lung injury and acute respiratory distress syndrome in adults, adolescents, children, infants and neonates.